超声造影联合增强CT诊断不典型肝血管平滑肌脂肪瘤的临床价值

doi:10.7517/issn.1674-0475.191116

摘要/Abstract

摘要： 选取2011年6月~2017年6月于我院就诊的经病理学检查明确确诊为肝血管平滑肌脂肪瘤（HAML）的43例患者，通过对纳入患者的49个HAML病灶的超声造影（CEUS）及增强CT（CECT）的影像学表现及术前诊断结果进行分析，探讨CEUS联合CECT在诊断不典型HAML中的临床价值。结果显示，HAML在女性中的发病率显著高于男性（P<0.001），且HAML多为单发病灶（P<0.001）。术前经CECT准确诊断HAML者有34.69%，经CEUS准确诊断HAML者有57.14%，二者联合准确诊断HAML者有77.55%，联合诊断的准确性显著高于单独应用CECT或CEUS（P<0.05）。HAML在CECT和CEUS上的表现具有一定的特征性，二者联合应用可以提高HAML诊断正确率。

关键词: 超声造影, 增强CT, 肝血管平滑肌脂肪瘤, 联合诊断

Abstract: 45 patients who were diagnosed with HAML by pathological examination in our hospital from June 2011 to June 2017 were enrolled. The imaging findings and preoperative diagnosis of CEUS and CECT in 49 HAML lesions of 43 patients were analyzed to explore the clinical value of contrast-enhanced ultrasound combined with enhanced CT in the diagnosis of atypical hepatic angiomyolipoma. The results showed that female patients were significantly more than male patients (P<0.001), and isolated HAML Patients were significantly more than multiple (P<0.001). In addition, 34.69% lesions were diagnosed as HAML by CECT, 57.14% lesions were diagnosed as HAML by CEUS, and 77.55% lesions were diagnosed as HAML by CEUS combined with CECT. The accuracy of CECT combined with CEUS was significantly higher than CECT or CEUS alone (P<0.05). The above results indicated the performance of HAML on CECT and CEUS has certain characteristics. The combination of the two can improve the diagnostic accuracy of HAML.

Key words: contrast-enhanced ultrasonography(CEUS), contrast-enhanced computed-tomography(CECT), hepatic angiomyolipoma(HAML), joint diagnosis

李士英, 陈金叶. 超声造影联合增强CT诊断不典型肝血管平滑肌脂肪瘤的临床价值[J]. 影像科学与光化学, 2020, 38(3): 496-502.

LI Shiying, CHEN Jinye. Clinical Value of Contrast-enhanced Ultrasound Combined with Enhanced CT in the Diagnosis of Atypical Hepatic Angiomyolipoma[J]. Imaging Science and Photochemistry, 2020, 38(3): 496-502.

参考文献

[1] Nonomura A, Mizukami Y, Kadoya M. Angiomyolipoma of the liver:a collective review[J]. Journal of Gastroenterology, 1994,29(1):95-105.
[2] Kamimura K, Nomoto M, Aoyagi Y. Hepatic angiomyolipoma:diagnostic findings and management[J]. International Journal of Hepatology, 2012,2012:410781.
[3] Yang X, Li A, Wu M. Hepatic angiomyolipoma:clinical, imaging and pathological features in 178 cases[J]. Medical Oncology, 2013,30(1):416.
[4] Chang Z, Zhang J M, Ying J Q, et al. Characteristics and treatment strategy of hepatic angiomyolipoma:a series of 94 patients collected from four institutions[J]. Journal of Gastrointestinal and Liver Diseases, 2011,20(1):65-69.
[5] Liu W, Meng Z, Liu H, et al. Hepatic epithelioid angiomyolipoma is a rare and potentially severe but treatable tumor:a report of three cases and review of the literature[J]. Oncology Letters, 2016,11(6):3669-3675.
[6] Högemann D, Flemming P, Kreipe H, et al. Correlation of MRI and CT findings with histopathology in hepatic angiomyolipoma[J]. European Radiology, 2001,11(8):1389-1395.
[7] Takayama Y, Moriura S, Nagata J, et al. Hepatic angiomyolipoma:radiologic and histopathologic correlation[J]. Abdominal Imaging, 2002,27(2):180-183.
[8] Li R, Zhang X, Hua X, et al. Real-time contrast-enhanced ultrasonography of resected and immunohistochemically proven hepatic angiomyolipomas[J]. Abdominal Imaging, 2010,35(6):676-682.
[9] Wang Z, Xu H X, Xie X Y, et al. Imaging features of hepatic angiomyolipomas on real-time contrast-enhanced ultrasound[J]. The British Journal of Radiology, 2010,83(989):411-418.
[10] Tsui W M, Colombari R, Portmann B C, et al. Hepatic angiomyolipoma:a clinicopathologic study of 30 cases and delineation of unusual morphologic variants[J]. The American Journal of Surgical Pathology, 1999,23(1):34-48.
[11] Li R, Tang C L, Cai P, et al. Comparison of CT and contrast-enhanced ultrasound findings in hepatic angiomyolipoma with pathological correlations[J]. Abdominal Radiology, 2016,41(2):248-256.
[12] Flemming P, Lehmann U, Becker T, et al. Common and epithelioid variants of hepatic angiomyolipoma exhibit clonal growth and share a distinctive immunophenotype[J]. Hepatology, 2000,32(2):213-217.
[13] Fetsch P A, Fetsch J F, Marincola F M, et al. Comparison of melanoma antigen recognized by T cells (MART-1) to HMB-45:additional evidence to support a common lineage for angiomyolipoma, lymphangiomyomatosis, and clear cell sugar tumor[J]. Modern Pathology, 1998,11(8):699-703.
[14] Yen Y H, Wang J H, Lu S N, et al. Contrast-enhanced ultrasonography in hepatic angiomyolipoma[J]. Journal of Ultrasound in Medicine, 2005,24(6):855-859.
[15] Wei H T, Liu H, Chen Y H, et al. The histopathological features and CT/MRI imaging performances in hepatic angiomyolipoma patients[J]. Annals of Hepatology, 2017,16(5):759-764.
[16] Petrolla A A, Xin W. Hepatic angiomyolipoma[J]. Archives of Pathology & Laboratory Medicine, 2008,132(10):1679-1682.
[17] Marrero J A, Ahn J, Reddy R K.ACG clinical guideline:the diagnosis and management of focal liver lesions[J]. The American Journal of Gastroenterology, 2014,109(9):1328-1347.
[18] Li R, Tang C L, Zhang Y, et al. Diagnosis of hepatic angiomyolipoma by combination of baseline and contrast-enhanced ultrasound-a prospective study in non-cirrhotic patients[J]. PloS One, 2015,10(7):e0132290.
[19] Ahmadi T, Itai Y, Takahashi M, et al. Angiomyolipoma of the liver:significance of CT and MR dynamic study[J]. Abdominal Imaging, 1998,23(5):520-526.
[20] Yeh H C, Klion F M, Thung S N, et al. Angiomyolipoma:ultrasonographic signs of lipomatous hepatic tumors[J]. Journal of Ultrasound in Medicine,1996,15(4):337-342.
[21] Goodman Z D, Ishak K G. Angiomyolipomas of the liver[J].The American Journal of Surgical Pathology, 1984,8(10):745-750.
[22] 徐少真, 潘江峰. 肝血管平滑肌脂肪瘤的MRI与CT影像表现[J]. 医学影像学杂志, 2016,26(4):658-661. Xu S Z, Pan J F. MRI and CT imaging manifestations of hepatic angiomyolipomas[J]. Journal of Medical Imaging, 2016,26(4):658-661.
[23] Prasad S R, Wang H, Rosas H, et al. Fat-containing lesions of the liver:radiologic-pathologic correlation[J]. Radiographics,2005,25(2):321-331.
[24] Anysz-Grodzicka A, Pacho R, Grodzicki M, et al. Angiomyolipoma of the liver:analysis of typical features and pitfalls based on own experience and literature[J]. Clinical Imaging, 2013,37(2):320-326.
[25] Cai P Q, Wu Y P, Xie C M, et al. Hepatic angiomyolipoma:CT and MR imaging findings with clinical-pathologic comparison[J]. Abdominal Imaging, 2013,38(3):482-489.
[26] Wei R X, Wang W P, Ding H, et al. Hepatic angiomyolipoma:contrast patterns with SonoVue-enhanced real-time gray-scale ultrasonography[J]. Asian Pacific Journal of Cancer Prevention, 2012,13(2):493-497.
[27] Ren N, Qin L X, Tang Z Y, et al. Diagnosis and treatment of hepatic angiomyolipoma in 26 cases[J]. World Journal of Gastroenterology, 2003,9(8):1856-1858.
[28] Bartolotta T V, Runza G, Minervini M, et al. Hepatic angiomyolipoma:contrast-enhanced pulse inversion US in a case[J]. La Radiologia Medica, 2003,105(5-6):514-518.
[29] Leen E, Ceccotti P, Kalogeropoulou C, et al. Prospective multicenter trial evaluating a novel method of characterizing focal liver lesions using contrast-enhanced sonography[J]. American Journal of Roentgenology, 2006,186(6):1551-1559.
[30] Ricci P, Laghi A, Cantisani V, et al. Contrast-enhanced sonography with SonoVue:enhancement patterns of benign focal liver lesions and correlation with dynamic gadobenate dimeglumine-enhanced MRI[J].American Journal of Roentgenology, 2005,184(3):821-827.
[31] Claudon M, Dietrich C F, Choi B I, et al. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver-update 2012:a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS[J].Ultrasound in Medicine & Biology, 2013,39(2):187-210.